Total Assets (Annual)

Total Assets: The sum of all assets on a company's balance sheet.

CorMedix Inc (CRMD) had Total Assets of $826.14M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$311.71M
Net Income	$163.06M
Cost of Goods Sold	$35.96M
Gross Profit	$275.75M
Operating Expenses	$161.57M
Operating Income	$150.14M
Non-Operating Income/Expense	$-0.12M
Pre-Tax Income	$150.02M
Normalized Pre-Tax Income	$150.02M
Income after Taxes	$163.06M
Income from Continuous Operations	$163.06M
Consolidated Net Income/Loss	$163.06M
Normalized Income after Taxes	$163.06M
EBIT	$150.14M
EBITDA	$165.53M
Weighted-Average Shares Outstanding (Basic)	72.03M
Weighted-Average Shares Outstanding (Diluted)	80.31M
Earnings per Share (EPS) (Basic)	$2.25
Earnings per Share (EPS) (Diluted)	$2.04
Balance Sheet Financials
Current Assets	$367.05M
Property, Plant, and Equipment	$5.96M
Long-Term Assets	$459.09M
Total Assets	$826.14M
Current Liabilities	$174.27M
Long-Term Debt	$145.21M
Long-Term Liabilities	$246.57M
Total Liabilities	$420.83M
Common Equity	$405.31M
Tangible Shareholders Equity	$-3.77M
Shareholders Equity	$405.31M
Common Shares Outstanding	79.26M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$175.05M
Cash Flow from Investing Activities	$-308.43M
Cash Flow from Financial Activities	$238.45M
Beginning Cash	$40.76M
End Cash	$145.82M
Increase/Decrease in Cash	$105.07M
Stock-Based Compensation	$13.83M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.11
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.26
Debt to Equity Ratio	0.36
Gross Margin	88.46%
Operating Margin	48.17%
EBIT Margin	48.17%
EBITDA Margin	53.10%
Pre-Tax Profit Margin	48.13%
Profit Margin	52.31%
Free Cash Flow	$172.79M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.38
Inventory Turnover	1.21
Receiveable Turnover	1.82
Days Sales in Receivables	200.51
Return on Equity	40.23%
Return on Tangible Equity	-4328.55%
Return on Assets	19.74%
Return on Investments	29.62%
Book Value Per Share	$5.11
Free Cash Flow per Share	$2.15
Operating Cash Flow per Share	$2.18

Data from Zacks Investment Research, Inc.